New cases of nephrogenic systemic fibrosis drop

June 10, 2008 New cases of nephrogenic systemic fibrosis drop James Brice -------------------------------------------------------------------------------- A status report on nephrogenic systemic fibrosis suggests that new cases of the rare but devastating skin disease associated with exposure to gadolinium-based MRI contrast media have slowed to a trickle since the introduction of regulatory restrictions in the U.S. and Europe in 2007. Speaking at an NSF update at the 2008 International Society for Magnetic Resonance in Medicine meeting, Dr. Tim Leiner, chair of the ISMRM working group on NSF, described data from GE Healthcare that suggest that the number of new cases associated with Omniscan (gadodiamide) dropped from a peak of 58 cases in 2006 to 19 cases in 2007.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC